CareDx Top-Tier Sponsor for Heart Failure Society of America Annual Scientific Meeting BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will host a symposium to describe […]
Other News
Catheter Precision’s VIVO™ Technology to be Featured in Three Presentations at the Global Society of Cardiac Robotic Navigation Annual Meeting
MT. OLIVE, N.J. & CARLSBAD, Calif.–(BUSINESS WIRE)–Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that its lead product, VIVO™ (View Into Ventricular Onset), will be featured in presentations by three physicians working in the field of cardiac electrophysiology at the Sixth Annual Society of […]
Biome Introduces the Next Generation in Performance Management Application for Cardiovascular Centers
The Biome Performance Manager™ simplifies and accelerates clinical and financial performance improvement across cardiovascular subspecialties. Clinicians, care teams, and hospital leadership leverage scarce resources to manage more initiatives, achieve goals faster, and sustain gains. SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leader in clinical performance solutions, is pleased to announce the release […]
UH Harrington Heart & Vascular Institute Recruits Renowned Cardiac Surgeon from Canada
Dr. Rakesh Arora to lead cardiac intensive care units and cardiac surgery research CLEVELAND – University Hospitals (UH) Harrington Heart & Vascular Institute has a rich history of providing the highest level of care for patients. Continuing as leaders in this field and elevating cardiac surgery patient care to a […]
Gracias Family Foundation Gives $3 Million to Help Drive a Cure for Heart Disease
UChicago Alumnus Antonio Gracias’ Family Foundation Invests in Early-Stage Atherosclerosis Research at The Pritzker School of Molecular Engineering The Gracias Family Foundation has committed $3 million to new early-stage nanomedicine research led by the University of Chicago’s Pritzker School of Molecular Engineering aimed at reducing atherosclerosis, the inflammation of the […]
Implicity Continues Rapid Growth and Expansion with Hiring of Two New Senior Leaders
Industry veterans Vanessa Joyce named VP of Sales for North America and Megan Grosz appointed Head of Global Marketing and Communications CAMBRIDGE, Mass., Sept. 28, 2022 /PRNewswire/ — Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced its continued growth with the appointment of two new senior-level executives. Vanessa Joyce was named the Company’s new Vice President […]
Mallinckrodt Announces Submission of 510(k) to the U.S. FDA for Inhaled Nitric Oxide Delivery System
— If 510(k) cleared, this next-generation investigational inhaled nitric oxide delivery system would be the latest in a long line of dual channel delivery systems building on Company’s dedication to meeting clinicians’ evolving needs — DUBLIN, Sept. 28, 2022 /PRNewswire/ — Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced the submission of a […]
Cytokinetics Announces Call for Proposals for Its Fifth Annual Communications Grant Program
Program to Provide $100,000 in Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular and Neuromuscular Diseases Deadline for Applications is November 11th, 2022 SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced a call for proposals for the fifth […]
HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
Patented Technology Allows HeartBeam AIMIGo™ Credit Card-sized Device to Enable a 12-lead ECG Anytime, Anywhere SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its patent that enables generation of a […]
REVA MEDICAL ANNOUNCES INITIATION OF ENROLLMENT IN THE MOTIV IDE CLINCIAL TRIAL
SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, today announced that enrollment in the MOTIV pivotal trial has been initiated at clinical centers in both the U.S. and Europe. The study will evaluate the use of the MOTIV® Sirolimus-Eluting Bioresorbable Vascular Scaffold for […]



